Stock listing

Jazz Pharmaceuticals Plc

Selected listing: J7Z · BX · CHF · CH

Jazz Pharmaceuticals Plc (BX Swiss: J7Z), Health Technology. Latest release Sep 15, 2026: Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences.

J7Z:BXCHFCHUpdated October 2, 2026

Ticker: BX Swiss: J7Z
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: BX Swiss
Currency: CHF

Latest news from Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

September 15, 2026

Ziihera® (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA

August 31, 2026

Jazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases

August 27, 2026

Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases

August 26, 2026

Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio

August 10, 2026

All Jazz Pharmaceuticals Plc news →

Events

Replays

Jazz Pharmaceuticals plc (JAZZ) Q2 2026 Earnings Call
Mon, Aug 03, 2026 · 04:30 PM ET
Watch
Jazz Pharmaceuticals plc (JAZZ) Q1 2026 Earnings Call
Tue, May 05, 2026 · 04:30 PM ET
Watch
Jazz Pharmaceuticals plc (JAZZ) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 04:30 PM ET
Watch

Research Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals Plc company profile

View the public company page for Jazz Pharmaceuticals Plc on 6ix.

Jazz Pharmaceuticals Plc news

Read company news and market updates connected to Jazz Pharmaceuticals Plc.

Jazz Pharmaceuticals Plc investor events

Find investor webinars, events, and replay context for Jazz Pharmaceuticals Plc.